Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Alterity Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Alterity moves to Phase 2 on cancer drug, Race Oncology secures 6th US patent
News
Closing Bell: ASX closes Wednesday 0.38% higher but short of all time high
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Small caps drop, but Afterpay breaks ATH at $159
News
10 at 10: These ASX stocks have put on the best show this morning
News
Last Orders: What you may have missed on the ASX today
News
Last Orders: What you might have missed on the ASX today
News
The 12 ASX stocks that gained over 400pc in a day in 2020
News
Last Orders: What you might have missed on the ASX today
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
10 at 10: These ASX stocks are casting a large shadow this morning
Health & Biotech
Check Up: Avecho leads the ASX healthcare stocks with progress on Propofol
News
ASX stocks in America: Opthea’s about to join the ranks but who’s there already?
Health & Biotech
The 6 ASX small cap biotechs that have more than doubled in 2020
Experts
Scopo’s powerplays: Strap yourselves in for some M&A
News
ASX Small Cap Lunch Wrap: Investor buys ‘GLDD’ instead of ‘GLD’ as a joke, still makes money
News
